RAS–RAF–MEK-dependent oxidative cell death involving voltage-dependent anion channels

The action mechanism of a RAS–RAF–MEK–pathway selective anti-tumour agent is described, this compound acts through mitochondrial voltage-dependent anion channels, a novel target for anti-cancer drugs.